Artal Group S.A.
- SEC CIK
- 0001053906
- Latest filing
- Aug 13, 2026
Holdings in Q1 2023
Holdings as of Mar 31, 2023, filed May 12, 2023. Long positions only; changes compare share counts with Q4 2022.
- Positions
- 118
- −7 vs. Q4 2022
- Portfolio value
- $1.68B
- −$52.0M (−3.0%) vs. Q4 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| LXRXLexicon Pharmaceuticals, Inc. | COM NEW | 89,778,234 | $218.2M | 13.0% | 00.0% | Unchanged | History |
| ONCBeOne Medicines Ltd. | ADR | 501,335 | $108.1M | 6.4% | −98,665−16.4% | Reduced | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 1,216,312 | $80.2M | 4.8% | +316,312+35.1% | Added | History |
| SRRKScholar Rock Holding Corp | COM | 9,027,950 | $72.2M | 4.3% | +47,680+0.5% | Added | History |
| MORFMorphic Holding, Inc. | COM | 1,813,949 | $68.3M | 4.1% | −336,051−15.6% | Reduced | History |
| WWWW International, Inc. | COM | 14,818,300 | $61.1M | 3.6% | 00.0% | Unchanged | History |
| MRTXMirati Therapeutics, Inc. | COM | 1,537,709 | $57.2M | 3.4% | −295,049−16.1% | Reduced | History |
| KYMRKymera Therapeutics, Inc. | COM | 1,805,346 | $53.5M | 3.2% | −194,654−9.7% | Reduced | History |
| CYTKCytokinetics Inc | COM NEW | 1,367,023 | $48.1M | 2.9% | +367,023+36.7% | Added | History |
| SWTXSpringWorks Therapeutics, Inc. | COM | 1,817,349 | $46.8M | 2.8% | −182,651−9.1% | Reduced | History |
| CERECerevel Therapeutics Holdings, Inc. | COM | 1,914,466 | $46.7M | 2.8% | +14,466+0.8% | Added | History |
| RVMDRevolution Medicines, Inc. | COM | 2,070,988 | $44.9M | 2.7% | +1,070,988+107.1% | Added | History |
| FOLDAmicus Therapeutics, Inc. | COM | 3,526,407 | $39.1M | 2.3% | −473,593−11.8% | Reduced | History |
| IGMSIGM Biosciences, Inc. | COM | 2,509,972 | $34.5M | 2.0% | +59,972+2.4% | Added | History |
| KRYSKrystal Biotech, Inc. | COM | 412,082 | $33.0M | 2.0% | +12,082+3.0% | Added | History |
| SAGESage Therapeutics, Inc. | COM | 750,000 | $31.5M | 1.9% | 00.0% | Unchanged | History |
| RLAYRelay Therapeutics, Inc. | COM | 1,673,743 | $27.6M | 1.6% | +219,027+15.1% | Added | History |
| SESea Ltd | SPONSORD ADS | 302,500 | $26.2M | 1.6% | +130,000+75.4% | Added | History |
| AGENAgenus Inc | COM NEW | 15,631,235 | $23.8M | 1.4% | +1,131,235+7.8% | Added | History |
| KLRSKalaris Therapeutics, Inc. | COM | 5,577,167 | $22.0M | 1.3% | 00.0% | Unchanged | History |
| VIGLVigil Neuroscience, Inc. | COM | 2,243,352 | $22.0M | 1.3% | 00.0% | Unchanged | History |
| KURAKura Oncology, Inc. | COM | 1,718,056 | $21.0M | 1.2% | +18,056+1.1% | Added | History |
| DNLIDenali Therapeutics Inc. | COM | 802,899 | $18.5M | 1.1% | +2,899+0.4% | Added | History |
| SDGRSchrodinger, Inc. | COM | 700,000 | $18.4M | 1.1% | 00.0% | Unchanged | History |
| SEERSeer, Inc. | COM CL A | 4,750,000 | $18.3M | 1.1% | 00.0% | Unchanged | History |
| VTYXVentyx Biosciences, Inc. | COM | 535,812 | $17.9M | 1.1% | +535,812 | New | History |
| OMGAOmega Therapeutics, Inc. | COMMON STOCK | 2,533,045 | $15.3M | 0.9% | +259,515+11.4% | Added | History |
| VORVor Biopharma Inc. | COM | 2,792,805 | $15.0M | 0.9% | −82,776−2.9% | Reduced | History |
| FATEFate Therapeutics Inc | COM | 2,600,000 | $14.8M | 0.9% | 00.0% | Unchanged | History |
| ERASErasca, Inc. | COM | 4,721,194 | $14.2M | 0.8% | +10,512+0.2% | Added | History |
| RXDXPrometheus Biosciences, Inc. | COM | 121,756 | $13.1M | 0.8% | +121,756 | New | History |
| WVEWave Life Sciences, Inc. | SHS | 3,000,000 | $13.0M | 0.8% | 00.0% | Unchanged | History |
| VRDNViridian Therapeutics, Inc. | COM | 504,978 | $12.8M | 0.8% | +504,978 | New | History |
| GBIOGeneration Bio Co. | COM | 2,814,191 | $12.1M | 0.7% | 00.0% | Unchanged | History |
| GERNGeron Corp | COM | 5,565,889 | $12.1M | 0.7% | +5,565,889 | New | History |
| TVTXTravere Therapeutics, Inc. | COM | 511,784 | $11.5M | 0.7% | +11,784+2.4% | Added | History |
| NTRANatera, Inc. | COM | 200,000 | $11.1M | 0.7% | 00.0% | Unchanged | History |
| AUPHAurinia Pharmaceuticals Inc. | COM | 1,000,000 | $11.0M | 0.7% | 00.0% | Unchanged | History |
| CBIOCrescent Biopharma, Inc. | COM | 8,589,064 | $10.8M | 0.6% | +8,589,064 | New | History |
| FHTXFoghorn Therapeutics Inc. | COM | 1,720,720 | $10.7M | 0.6% | 00.0% | Unchanged | History |
| NTLAIntellia Therapeutics, Inc. | COM | 276,077 | $10.3M | 0.6% | +1,077+0.4% | Added | History |
| ALPNAlpine Immune Sciences, Inc. | COM | 1,193,030 | $9.21M | 0.5% | 00.0% | Unchanged | History |
| ARAVAravive, Inc. | COM | 4,572,515 | $9.14M | 0.5% | 00.0% | Unchanged | History |
| MRSNMersana Therapeutics, Inc. | COM | 2,215,788 | $9.11M | 0.5% | +15,788+0.7% | Added | History |
| REPLReplimune Group, Inc. | COM | 500,000 | $8.83M | 0.5% | −200,000−28.6% | Reduced | History |
| BBIOBridgeBio Pharma, Inc. | COM | 500,000 | $8.29M | 0.5% | +250,000+100.0% | Added | History |
| Avidity Biosciences, Inc.05370A108 | COM | 511,962 | $7.86M | 0.5% | +11,962+2.4% | Added | – |
| TGTXTG Therapeutics, Inc. | COM | 511,389 | $7.69M | 0.5% | +511,389 | New | History |
| TSVT2seventy bio, Inc. | COMMON STOCK | 750,000 | $7.65M | 0.5% | +750,000 | New | History |
| ETNB89bio, Inc. | COM | 500,000 | $7.62M | 0.5% | +100,000+25.0% | Added | History |
| FUSNFusion Pharmaceuticals Inc. | COM | 1,975,000 | $7.45M | 0.4% | +1,225,000+163.3% | Added | History |
| RPTXRepare Therapeutics Inc. | COM | 700,000 | $6.89M | 0.4% | 00.0% | Unchanged | History |
| RNACCartesian Therapeutics, Inc. | COM | 4,883,200 | $6.79M | 0.4% | 00.0% | Unchanged | History |
| PLRXPliant Therapeutics, Inc. | COM | 255,085 | $6.79M | 0.4% | +255,085 | New | History |
| OVIDOvid Therapeutics Inc. | COM | 2,500,000 | $6.45M | 0.4% | 00.0% | Unchanged | History |
| AMAMAmbrx Biopharma Cayman, Inc. | SPONSORED ADS | 702,291 | $6.26M | 0.4% | −1,450,000−67.4% | Reduced | History |
| DYNDyne Therapeutics, Inc. | COM | 532,609 | $6.14M | 0.4% | +7,609+1.4% | Added | History |
| KDNYChinook Therapeutics, Inc. | COM | 258,687 | $5.99M | 0.4% | +258,687 | New | History |
| ITOSiTeos Therapeutics, Inc. | COM | 400,000 | $5.44M | 0.3% | 00.0% | Unchanged | History |
| IMAImageneBio, Inc. | COM | 1,549,513 | $5.35M | 0.3% | 00.0% | Unchanged | History |
| BEKEKE Holdings Inc. | SPONSORED ADS | 275,000 | $5.18M | 0.3% | −225,000−45.0% | Reduced | History |
| VKTXViking Therapeutics, Inc. | COM | 300,000 | $5.00M | 0.3% | +300,000 | New | History |
| ROIVRoivant Sciences Ltd. | SHS | 600,000 | $4.43M | 0.3% | +600,000 | New | History |
| VERVVerve Therapeutics, Inc. | COM | 300,000 | $4.33M | 0.3% | 00.0% | Unchanged | History |
| SLDBSolid Biosciences Inc. | COM NEW | 909,219 | $4.31M | 0.3% | 00.0% | Unchanged | History |
| SYRSSyros Pharmaceuticals, Inc. | COM NEW | 1,475,744 | $3.94M | 0.2% | +11,915+0.8% | Added | History |
| ANNXAnnexon, Inc. | COM | 1,018,303 | $3.92M | 0.2% | +1,018,303 | New | History |
| PFTAPerception Capital Corp. III | CLASS A ORD SHS | 380,000 | $3.89M | 0.2% | 00.0% | Unchanged | History |
| GOSSGossamer Bio, Inc. | COM | 3,028,171 | $3.81M | 0.2% | −218,453−6.7% | Reduced | History |
| NBTXNanobiotix S.A. | SPONSORED ADS | 1,000,000 | $3.52M | 0.2% | 00.0% | Unchanged | History |
| SLNSilence Therapeutics plc | ADS | 505,074 | $3.13M | 0.2% | +505,074 | New | History |
| BDTXBlack Diamond Therapeutics, Inc. | COM | 1,646,517 | $3.11M | 0.2% | 00.0% | Unchanged | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 31,967 | $3.11M | 0.2% | +31,967 | New | History |
| NBPNovaBridge Biosciences | SPONSORED ADS | 850,000 | $2.94M | 0.2% | 00.0% | Unchanged | History |
| TSMTaiwan Semiconductor Manufacturing Co Ltd | ADR | 30,000 | $2.79M | 0.2% | +30,000 | New | History |
| CGEMCullinan Therapeutics, Inc. | COM | 250,000 | $2.56M | 0.2% | 00.0% | Unchanged | History |
| ALXOAlx Oncology Holdings Inc | COM | 500,000 | $2.26M | 0.1% | 00.0% | Unchanged | History |
| KRONKronos Bio, Inc. | COM | 1,542,954 | $2.25M | 0.1% | 00.0% | Unchanged | History |
| Achilles Therapeutics PLC00449L102 | SPONSORED ADS | 2,255,375 | $2.16M | 0.1% | 00.0% | Unchanged | – |
| STOKStoke Therapeutics, Inc. | COM | 250,000 | $2.08M | 0.1% | 00.0% | Unchanged | History |
| IMUXImmunic, Inc. | COM | 1,274,713 | $1.90M | 0.1% | 00.0% | Unchanged | History |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 75,000 | $1.78M | 0.1% | +75,000 | New | History |
| TRMLTourmaline Bio, Inc. | COM | 914,262 | $1.72M | 0.1% | −1,150,000−55.7% | Reduced | History |
| MEHCQChrome Holding Co. | CLASS A COM | 661,009 | $1.51M | 0.1% | 00.0% | Unchanged | History |
| ADAGAdagene Inc. | ADS | 1,000,000 | $1.45M | 0.1% | 00.0% | Unchanged | History |
| XLOXilio Therapeutics, Inc. | COM | 450,000 | $1.43M | 0.1% | 00.0% | Unchanged | History |
| HOOKHOOKIPA Pharma Inc. | COM | 1,849,616 | $1.36M | 0.1% | 00.0% | Unchanged | History |
| CYPHCypherpunk Technologies Inc. | COM | 4,000,000 | $1.36M | 0.1% | 00.0% | Unchanged | History |
| SANASana Biotechnology, Inc. | COM | 400,000 | $1.31M | 0.1% | 00.0% | Unchanged | History |
| KRSAKorsana Biosciences, Inc. | COM | 2,779,122 | $1.21M | 0.1% | 00.0% | Unchanged | History |
| IRWDIronwood Pharmaceuticals Inc | COM CL A | 110,532 | $1.16M | 0.1% | 00.0% | Unchanged | History |
| TSHATaysha Gene Therapies, Inc. | COM SHS | 1,440,882 | $1.15M | 0.1% | 00.0% | Unchanged | History |
| TCRRTCR2 Therapeutics Inc. | COM | 750,000 | $1.13M | 0.1% | 00.0% | Unchanged | History |
| SQZSQZ Biotechnologies Co | COM | 1,606,309 | $900.0K | 0.1% | 00.0% | Unchanged | History |
| KNTEKinnate Biopharma Inc. | COM | 125,000 | $781.0K | <0.1% | 00.0% | Unchanged | History |
| CRISCuris Inc | COM NEW | 1,300,000 | $775.0K | <0.1% | 00.0% | Unchanged | History |
| HARPHarpoon Therapeutics, Inc. | COM | 1,000,000 | $744.0K | <0.1% | 00.0% | Unchanged | History |
| UTHRUnited Therapeutics Corp | COM | 3,281 | $735.0K | <0.1% | +3,281 | New | History |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 26,173 | $665.0K | <0.1% | +26,173 | New | History |
| BCRXBiocryst Pharmaceuticals Inc | COM | 67,909 | $566.0K | <0.1% | +67,909 | New | History |
Sold out since Q4 2022 (34)
Positions held at the end of Q4 2022 that are gone from this filing.
| Security | Class | Shares in Q4 2022 | Value in Q4 2022 | % of portfolio in Q4 2022 | History |
|---|---|---|---|---|---|
| Bellus Health Inc New07987C204 | COM NEW | 3,700,000 | $30.4M | 1.8% | – |
| ISEEIVERIC bio, Inc. | COM | 1,000,000 | $21.4M | 1.2% | History |
| INSMINSMED Inc | COM PAR $.01 | 500,000 | $9.99M | 0.6% | History |
| EVOEvotec SE | SPONSORED ADS | 1,149,425 | $9.30M | 0.5% | History |
| RXRXRecursion Pharmaceuticals, Inc. | CL A | 960,204 | $7.40M | 0.4% | History |
| BHVNBiohaven Ltd. | COM | 500,000 | $6.94M | 0.4% | History |
| GRTSGritstone bio, Inc. | COM | 1,856,194 | $6.40M | 0.4% | History |
| EQRXEQRx, Inc. | COM | 2,000,000 | $4.92M | 0.3% | History |
| AURAAura Biosciences, Inc. | COM | 410,000 | $4.30M | 0.2% | History |
| ZYMEZymeworks Inc. | COM | 450,000 | $3.54M | 0.2% | History |
| MIRMirion Technologies, Inc. | COM CL A | 500,000 | $3.31M | 0.2% | History |
| Exscientia PLC30223G102 | ADS | 550,000 | $2.93M | 0.2% | – |
| PRAXPraxis Precision Medicines, Inc. | COM | 1,200,000 | $2.86M | 0.2% | History |
| OTLYOatly Group AB | SPONSORED ADS | 1,500,000 | $2.61M | 0.2% | History |
| LYELLyell Immunopharma, Inc. | COM | 700,000 | $2.43M | 0.1% | History |
| ORICOric Pharmaceuticals, Inc. | COM | 400,000 | $2.36M | 0.1% | History |
| LENZLENZ Therapeutics, Inc. | COM | 700,000 | $2.32M | 0.1% | History |
| ACIUAC Immune SA | SHS | 1,000,000 | $2.04M | 0.1% | History |
| YMABY-mAbs Therapeutics, Inc. | COM | 400,000 | $1.95M | 0.1% | History |
| IMMPIMMUTEP Ltd | SPONSORED ADS | 1,000,000 | $1.75M | 0.1% | History |
| APTXAptinyx Inc. | COM | 6,116,493 | $1.75M | 0.1% | History |
| MREOMereo BioPharma Group plc | SPON ADS | 1,500,000 | $1.13M | 0.1% | History |
| CRDFCardiff Oncology, Inc. | COM | 750,000 | $1.05M | 0.1% | History |
| TSLATesla, Inc. | Stock | 6,300 | $776.0K | <0.1% | History |
| ORTXOrchard Therapeutics plc | ADS | 1,803,858 | $669.0K | <0.1% | History |
| OLMAOlema Pharmaceuticals, Inc. | COM | 260,500 | $638.0K | <0.1% | History |
| APLTApplied Therapeutics, Inc. | COM | 400,000 | $304.0K | <0.1% | History |
| NEXINexImmune, Inc. | COM | 1,200,000 | $292.0K | <0.1% | History |
| TILInstil Bio, Inc. | COM | 450,000 | $284.0K | <0.1% | History |
| PANWPalo Alto Networks Inc | Stock | 2,000 | $279.0K | <0.1% | History |
| LITSLite Strategy, Inc. | COM NEW | 1,000,000 | $244.0K | <0.1% | History |
| CDTXCidara Therapeutics, Inc. | COM | 224,675 | $170.0K | <0.1% | History |
| CFRXCONTRAFECT Corp | COM NEW | 1,500,000 | $144.0K | <0.1% | History |
| CDAKCodiak BioSciences, Inc. | COM | 200,000 | $80.0K | <0.1% | History |